Cilostazol and Nimodipine Combined Therapy After Aneurysmal Subarachnoid Hemorrhage (aSAH)

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
The investigators seek to demonstrate that the combined use of cilostazol and nimodipine will significantly decrease the rate of delayed cerebral infarction and cerebral vasospasm after cerebrovascular intervention when compared to nimodipine alone.
Epistemonikos ID: afb75b9b18798266910ed1d59c2c124377c4f52a
First added on: May 06, 2024